The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses
Open accessAbstract
Endometrial cancer is a clinically heterogeneous disease and it is becoming increasingly clear that this heterogeneity may be a function of the diversity of the underlying molecular alterations. Recent large‐scale genomic studies have revealed that endometrial cancer can be divided into at least four distinct molecular subtypes, with well‐described underlying genomic aberrations. These subtypes can be reliably delineated and carry significant prognostic as well as predictive information; embracing and incorporating them into clinical practice is thus attractive. The road towards the integration of molecular features into current classification systems is not without obstacles. Collaborative studies engaging research teams from across the world are working to define pragmatic assays, improve risk stratification systems by combining molecular features and traditional clinicopathological parameters, and determine how molecular classification can be optimally utilized to direct patient care. Pathologists and clinicians caring for women with endometrial cancer need to engage with and understand the possibilities and limitations of this new approach, because integration of molecular classification of endometrial cancers is anticipated to become an essential part of gynaecological pathology practice. This review will describe the challenges in current systems of endometrial carcinoma classification, the evolution of new molecular technologies that define prognostically distinct molecular subtypes, and potential applications of molecular classification as a step towards precision medicine and refining care for individuals with the most common gynaecological cancer in the developed world. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784
Neoantigens in cancer immunotherapy
Schumacher, T. N., & Schreiber, R. D. (2015) · Science · doi:10.1126/science.aaa4971 · Cited by 4,783
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.001 · Cited by 4,229
Two pathogenetic types of endometrial carcinoma
Bokhman, J. V. (1983) · Gynecologic Oncology · doi:10.1016/0090-8258(83)90111-7 · Cited by 2,494
The diverse functions of the PD1 inhibitory pathway
Sharpe, A. H., & Pauken, K. E. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.108 · Cited by 1,971
Creutzberg, C. L., van Putten, W. L., Koper, P. C., Lybeert, M. L., Jobsen, J. J., Wárlám-Rodenhuis, C. C., De Winter, K. A., Lutgens, L. C., van den Bergh, A. C., van de Steen-Banasik, E., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02139-5 · Cited by 1,773
Keys, H. M., Roberts, J. A., Brunetto, V. L., Zaino, R. J., Spirtos, N. M., Bloss, J. D., Pearlman, A., Maiman, M. A., & Bell, J. G. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.11.048 · Cited by 1,671
The multifaceted mismatch-repair system
Jiricny, J. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1907 · Cited by 1,370
Nout, R., Smit, V., Putter, H., Jürgenliemk-Schulz, I., Jobsen, J., Lutgens, L., van der Steen-Banasik, E., Mens, J., Slot, A., Kroese, M. S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62163-2 · Cited by 1,150
Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer
Talhouk, A., McConechy, M. K., Leung, S., Yang, W., Lum, A., Senz, J., Boyd, N., Pike, J., Anglesio, M., Kwon, J. S., et al. (2017) · Cancer · doi:10.1002/cncr.30496 · Cited by 975
Self-citationA clinically applicable molecular-based classification for endometrial cancers
Talhouk, A., McConechy, M. K., Leung, S., Li-Chang, H. H., Kwon, J. S., Melnyk, N., Yang, W., Senz, J., Boyd, N., Karnezis, A. N., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.190 · Cited by 971
Self-citationStelloo, E., Nout, R. A., Osse, E. M., Jürgenliemk-Schulz, I. J., Jobsen, J. J., Lutgens, L. C., van der Steen-Banasik, E. M., Nijman, H. W., Putter, H., Bosse, T., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2878 · Cited by 846
Self-citationLigtenberg, M. J. L., Kuiper, R. P., Chan, T. L., Goossens, M., Hebeda, K. M., Voorendt, M., Lee, T. Y. H., Bodmer, D., Hoenselaar, E., Hendriks-Cornelissen, S. J. B., et al. (2009) · Nature Genetics · doi:10.1038/ng.283 · Cited by 818
Mariani, A., Dowdy, S. C., Cliby, W. A., Gostout, B. S., Jones, M. B., Wilson, T. O., & Podratz, K. C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.01.023 · Cited by 810
Comprehensive Analysis of Hypermutation in Human Cancer
Campbell, B. B., Light, N., Fabrizio, D., Zatzman, M., Fuligni, F., de Borja, R., Davidson, S., Edwards, M., Elvin, J. A., Hodel, K. P., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.048 · Cited by 765
Howitt, B. E., Shukla, S. A., Sholl, L. M., Ritterhouse, L. L., Watkins, J. C., Rodig, S., Stover, E., Strickland, K. C., D’Andrea, A. D., Wu, C. J., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2151 · Cited by 684
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Colombo, N., Preti, E., Landoni, F., Carinelli, S., Colombo, A., Marini, C., & Sessa, C. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt353 · Cited by 600
Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
Brown, S. D., Warren, R. L., Gibb, E. A., Martin, S. D., Spinelli, J. J., Nelson, B. H., & Holt, R. A. (2014) · Genome Research · doi:10.1101/gr.165985.113 · Cited by 594
Yemelyanova, A., Vang, R., Kshirsagar, M., Lu, D., Marks, M. A., Shih, I. M., & Kurman, R. J. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.85 · Cited by 513
Ott, P. A., Bang, Y.-J., Berton-Rigaud, D., Elez, E., Pishvaian, M. J., Rugo, H. S., Puzanov, I., Mehnert, J. M., Aung, K. L., Lopez, J., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.5952 · Cited by 506
Stelloo, E., Bosse, T., Nout, R. A., MacKay, H. J., Church, D. N., Nijman, H. W., Leary, A., Edmondson, R. J., Powell, M. E., Crosbie, E. J., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.43 · Cited by 486
Self-citationSusumu, N., Sagae, S., Udagawa, Y., Niwa, K., Kuramoto, H., Satoh, S., & Kudo, R. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.09.029 · Cited by 445
Integrated Molecular Characterization of Uterine Carcinosarcoma
Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., Hu, X., Ling, S., Soslow, R. A., Broaddus, R. R., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.010 · Cited by 434
Maggi, R., Lissoni, A., Spina, F., Melpignano, M., Zola, P., Favalli, G., Colombo, A., & Fossati, R. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603279 · Cited by 421
Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma
Gilks, C. B., Oliva, E., & Soslow, R. A. (2013) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31827f576a · Cited by 401
Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma
Köbel, M., Piskorz, A. M., Lee, S., Lui, S., LePage, C., Marass, F., Rosenfeld, N., Mes Masson, A., & Brenton, J. D. (2016) · The Journal of Pathology: Clinical Research · doi:10.1002/cjp2.53 · Cited by 387
Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer
Mehnert, J. M., Panda, A., Zhong, H., Hirshfield, K., Damare, S., Lane, K., Sokol, L., Stein, M. N., Rodriguez-Rodriquez, L., Kaufman, H. L., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84940 · Cited by 380
Lu, K. H., Dinh, M., Kohlmann, W., Watson, P., Green, J., Syngal, S., Bandipalliam, P., Chen, L.-M., Allen, B., Conrad, P., et al. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000154885.44002.ae · Cited by 379
A panoply of errors: polymerase proofreading domain mutations in cancer
Rayner, E., van Gool, I. C., Palles, C., Kearsey, S. E., Bosse, T., Tomlinson, I., & Church, D. N. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.12 · Cited by 373
Self-citationEvolution of Translational Omics: Lessons Learned and the Path Forward
Micheel, C., Nass, S. J., & Omenn, G. S. (2013) · Cited by 365
Sepulveda, A. R., Hamilton, S. R., Allegra, C. J., Grody, W., Cushman-Vokoun, A. M., Funkhouser, W. K., Kopetz, S. E., Lieu, C., Lindor, N. M., Minsky, B. D., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.9807 · Cited by 360
DNA polymerase ɛ and δ exonuclease domain mutations in endometrial cancer
Church, D. N., Briggs, S. E. W., Palles, C., Domingo, E., Kearsey, S. J., Grimes, J. M., Gorman, M., Martin, L., Howarth, K. M., Hodgson, S. V., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt131 · Cited by 352
Practical guidance for mismatch repair-deficiency testing in endometrial cancer
Stelloo, E., Jansen, A. M. L., Osse, E. M., Nout, R. A., Creutzberg, C. L., Ruano, D., Church, D. N., Morreau, H., Smit, V. T. H. B. M., van Wezel, T., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdw542 · Cited by 342
Self-citationBosse, T., Nout, R. A., McAlpine, J. N., McConechy, M. K., Britton, H., Hussein, Y. R., Gonzalez, C., Ganesan, R., Steele, J. C., Harrison, B. T., et al. (2018) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001020 · Cited by 341
Self-citationKurnit, K. C., Kim, G. N., Fellman, B. M., Urbauer, D. L., Mills, G. B., Zhang, W., & Broaddus, R. R. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.15 · Cited by 325
POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
van Gool, I. C., Eggink, F. A., Freeman-Mills, L., Stelloo, E., Marchi, E., de Bruyn, M., Palles, C., Nout, R. A., de Kroon, C. D., Osse, E. M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0057 · Cited by 320
Self-citationSimpkins, S. B., Bocker, T., Swisher, E. M., Mutch, D. G., Gersell, D. J., Kovatich, A. J., Palazzo, J. P., Fishel, R., & Goodfellow, P. J. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.661 · Cited by 319
Shevelev, I. V., & Hübscher, U. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm804 · Cited by 284
Shinbrot, E., Henninger, E. E., Weinhold, N., Covington, K. R., Göksenin, A. Y., Schultz, N., Chao, H., Doddapaneni, H., Muzny, D. M., Gibbs, R. A., et al. (2014) · Genome Research · doi:10.1101/gr.174789.114 · Cited by 278
Gilks, C. B., Ionescu, D. N., Kalloger, S. E., Köbel, M., Irving, J., Clarke, B., Santos, J., Le, N., Moravan, V., & Swenerton, K. (2008) · Human Pathology · doi:10.1016/j.humpath.2008.01.003 · Cited by 242
Stadler, Z. K., Battaglin, F., Middha, S., Hechtman, J. F., Tran, C., Cercek, A., Yaeger, R., Segal, N. H., Varghese, A. M., Reidy-Lagunes, D. L., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.1067 · Cited by 234
Liu, Y., Patel, L., Mills, G. B., Lu, K. H., Sood, A. K., Ding, L., Kucherlapati, R., Mardis, E. R., Levine, D. A., Shmulevich, I., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju245 · Cited by 228
The genetic landscape of endometrial clear cell carcinomas
DeLair, D. F., Burke, K. A., Selenica, P., Lim, R. S., Scott, S. N., Middha, S., Mohanty, A. S., Cheng, D. T., Berger, M. F., Soslow, R. A., et al. (2017) · The Journal of Pathology · doi:10.1002/path.4947 · Cited by 227
L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter Evaluation
Zeimet, A. G., Reimer, D., Huszar, M., Winterhoff, B., Puistola, U., Abdel Azim, S., Müller-Holzner, E., Ben-Arie, A., van Kempen, L. C., Petru, E., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt144 · Cited by 226
Talhouk, A., Hoang, L. N., McConechy, M. K., Nakonechny, Q., Leo, J., Cheng, A., Leung, S., Yang, W., Lum, A., Köbel, M., et al. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.07.090 · Cited by 225
Self-citationUbiquitination and Degradation of Mutant p53
Lukashchuk, N., & Vousden, K. H. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00050-07 · Cited by 223
Hussein, Y. R., Weigelt, B., Levine, D. A., Schoolmeester, J. K., Dao, L. N., Balzer, B. L., Liles, G., Karlan, B., Köbel, M., Lee, C.-H., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2014.143 · Cited by 220
Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis
Reid-Nicholson, M., Iyengar, P., Hummer, A. J., Linkov, I., Asher, M., & Soslow, R. A. (2006) · Modern Pathology · doi:10.1038/modpathol.3800620 · Cited by 219
McConechy, M. K., Talhouk, A., Li-Chang, H. H., Leung, S., Huntsman, D. G., Gilks, C. B., & McAlpine, J. N. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.01.541 · Cited by 218
Self-citationSteady-state Regulation of the Human DNA Mismatch Repair System
Chang, D. K., Ricciardiello, L., Goel, A., Chang, C. L., & Boland, C. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001140200 · Cited by 210
Reproducibility of histological cell type in high-grade endometrial carcinoma
Han, G., Sidhu, D., Duggan, M. A., Arseneau, J., Cesari, M., Clement, P. B., Ewanowich, C. A., Kalloger, S. E., & Köbel, M. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.102 · Cited by 203
Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis
McConechy, M. K., Talhouk, A., Leung, S., Chiu, D., Yang, W., Senz, J., Reha-Krantz, L. J., Lee, C.-H., Huntsman, D. G., Gilks, C. B., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2233 · Cited by 190
Self-citationJones, S., Stransky, N., McCord, C. L., Cerami, E., Lagowski, J., Kelly, D., Angiuoli, S. V., Sausen, M., Kann, L., Shukla, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms6006 · Cited by 166
Nowak, J. A., Yurgelun, M. B. B., Bruce, J. L., Rojas‐Rudilla, V., Hall, D. L., Shivdasani, P., Garcia, E. P., Agoston, A. T., Srivastava, A., Ogino, S., et al. (2016) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2016.07.010 · Cited by 166
Bosse, T., Nout, R. A., Stelloo, E., Dreef, E., Nijman, H. W., Jürgenliemk-Schulz, I. M., Jobsen, J. J., Creutzberg, C. L., & Smit, V. T. H. B. M. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.07.014 · Cited by 161
Self-citationSantin, A. D., Bellone, S., Buza, N., Choi, J., Schwartz, P. E., Schlessinger, J., & Lifton, R. P. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1031 · Cited by 160
Alkushi, A., Köbel, M., Kalloger, S. E., & Gilks, C. B. (2010) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e3181cd6552 · Cited by 158
Trovik, J., Wik, E., Werner, H. M. J., Krakstad, C., Helland, H., Vandenput, I., Njølstad, T. S., Stefansson, I. M., Marcickiewicz, J., Tingulstad, S., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.06.016 · Cited by 158
FDA grants accelerated approval to pembrolizumab for first tissue/site agnostic indication
Administration, U. S. F. &. D. (2017) · Case Medical Research · doi:10.31525/fda1-ucm560040.htm · Cited by 158
Diagnosis of Ovarian Carcinoma Cell Type is Highly Reproducible: A Transcanadian Study
Köbel, M., Kalloger, S. E., Baker, P. M., Ewanowich, C. A., Arseneau, J., Zherebitskiy, V. A., Abdulkarim, S., Leung, S. C. Y., Duggan, M. A., Fontaine, D., et al. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181e1a3bb · Cited by 148
Wik, E., Raeder, M. B., Krakstad, C., Trovik, J., Birkeland, E., Høivik, E. A., Mjøs, S., Werner, H. M. J., Mannelqvist, M., Stefansson, I. M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3039 · Cited by 143
Hall, G., Clarkson, A., Shi, A., Langford, E., Leung, H., Eckstein, R. P., & Gill, A. J. (2010) · Pathology · doi:10.3109/00313025.2010.493871 · Cited by 143
Just how accurate are the major risk stratification systems for early-stage endometrial cancer?
Bendifallah, S., Canlorbe, G., Collinet, P., Arsène, E., Huguet, F., Coutant, C., Hudry, D., Graesslin, O., Raimond, É., Touboul, C., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.35 · Cited by 140
Wnt/Β-Catenin and Sex Hormone Signaling In Endometrial Homeostasis and Cancer
Wang, Y., van der Zee, M., Fodde, R., & Blok, L. J. (2010) · Oncotarget · doi:10.18632/oncotarget.201 · Cited by 134
TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers
Schultheis, A. M., Martelotto, L. G., Filippo, M. R. D., Piscuglio, S., Ng, C. K. Y., Hussein, Y. R., Reis-Filho, J. S., Soslow, R. A., & Weigelt, B. (2015) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000243 · Cited by 134
Weissman, S. M., Burt, R. W., Church, J. M., Erdman, S., Hampel, H., Holter, S., Jasperson, K. W., Kalady, M. F., Haidle, J. L., Lynch, H. T., et al. (2011) · Journal of Genetic Counseling · doi:10.1007/s10897-011-9465-7 · Cited by 132
Eggink, F. A., van Gool, I. C., Leary, A. F., Pollock, P. M., Crosbie, E. J., Mileshkin, L., Jordanova, E. S., Adam, J., Freeman-Mills, L., Church, D. N., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1264565 · Cited by 132
Self-citationCosgrove, C. M., Cohn, D. E., Hampel, H., Frankel, W. L., Jones, D. M., McElroy, J. P., Suarez, A. A., Zhao, W., Chen, W., Salani, R., et al. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.07.003 · Cited by 126
Karnezis, A. N., Leung, S. C. Y., Magrill, J., McConechy, M. K., Yang, W., Chow, C., Köbel, M., Lee, C., Huntsman, D. D., Talhouk, A., et al. (2017) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.82 · Cited by 126
Self-citationLeenen, C. H., van Lier, M. G., van Doorn, H. C., van Leerdam, M. E., Kooi, S. G., de Waard, J., Hoedemaeker, R. F., van den Ouweland, A. M. W., Hulspas, S., Dubbink, H. J., et al. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.01.049 · Cited by 118
Bartosch, C., Lopes, J. M., & Oliva, E. (2011) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e318234ab18 · Cited by 101
L1CAM expression in endometrial carcinomas: an ENITEC collaboration study
van der Putten, L. J. M., Visser, N. C. M., de Vijver, K. K. V., Santacana, M., Bronsert, P., Bulten, J., Hirschfeld, M., Colás, E., Gil‐Moreno, A., García, Á., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.235 · Cited by 99
DNA polymerase ε and its roles in genome stability
Henninger, E. E., & Pursell, Z. F. (2014) · IUBMB Life · doi:10.1002/iub.1276 · Cited by 97
Bakhsh, S. I. A., Kinloch, M. A., Hoang, L. N., Soslow, R. A., Köbel, M., Lee, C., McAlpine, J. N., McConechy, M. K., & Gilks, C. B. (2015) · Histopathology · doi:10.1111/his.12878 · Cited by 97
Self-citationUnusual Mismatch Repair Immunohistochemical Patterns in Endometrial Carcinoma
Watkins, J. C., Nucci, M. R., Ritterhouse, L. L., Howitt, B. E., & Sholl, L. M. (2016) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000663 · Cited by 92
van Gool, I. C., Stelloo, E., Nout, R. A., Nijman, H. W., Edmondson, R. J., Church, D. N., MacKay, H. J., Leary, A. F., Powell, M. E. B., Mileshkin, L., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2015.147 · Cited by 91
Self-citationAga, S. S., Nissar, S., & Fatima, K. (2014) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000019 · Cited by 76
Gallo, M. L., Rudd, M. L., Urick, M. E., Hansen, N. F., Zhang, S., Program, N. C. S., Lozy, F., Sgroi, D. C., Vidal, A., Matías‐Guiu, X., et al. (2017) · Cancer · doi:10.1002/cncr.30745 · Cited by 75
Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
Depreeuw, J., Stelloo, E., Osse, E. M., Creutzberg, C. L., Nout, R. A., Moisse, M., Garcia-Dios, D. A., Dewaele, M., Willekens, K., Marine, J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0566 · Cited by 59
Self-citationNovel Implications in Molecular Diagnosis of Lynch Syndrome
Liccardo, R., Rosa, M. D., Izzo, P., & Duraturo, F. (2017) · Gastroenterology Research and Practice · doi:10.1155/2017/2595098 · Cited by 47
Russo, M., Broach, J. R., Sheldon, K. E., Houser, K. R., Liu, D. J., Kesterson, J. P., Phaëton, R., Hossler, C., Hempel, N., Baker, M. J., et al. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.07.003 · Cited by 41
Köbel, M., Atenafu, E. G., Rambau, P., Ferguson, S. E., Nelson, G. S., Ho, T. C., Panzarella, T., McAlpine, J. N., Gilks, C. B., Clarke, B. A., et al. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.04.008 · Cited by 35
Self-citationLimited impact of intratumour heterogeneity on molecular risk assignment in endometrial cancer
van Esterik, M., van Gool, I. C., de Kroon, C. D., Nout, R. A., Creutzberg, C. L., Smit, V. T. H. B. M., Bosse, T., & Stelloo, E. (2017) · Oncotarget · doi:10.18632/oncotarget.16067 · Cited by 18
Self-citationIdentifying Lynch Syndrome in Women Presenting With Endometrial Carcinoma Under the Age of 50 Years
Anagnostopoulos, A., McKay, V. H., Cooper, I., Campbell, F., Greenhalgh, L., & Kirwan, J. (2017) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000962 · Cited by 18
Cited by
ESGO/ESTRO/ESP Guidelines for the Management of Patients with Endometrial Carcinoma
Concin, N., Matias-Guiu, X., Vergote, I., Cibula, D., Mirza, M. R., Marnitz, S., Ledermann, J., Bosse, T., Chargari, C., Fagotti, A., et al. (2021) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2020-002230 · Cited by 1,989
Self-citationThe immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Bruni, D., Angell, H. K., & Galon, J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0285-7 · Cited by 1,586
Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Oaknin, A., Bosse, T. J., Creutzberg, C. L., Giornelli, G., Harter, P., Joly, F., Lorusso, D., Marth, C., Makker, V., Mirza, M. R., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.05.009 · Cited by 652
Self-citation
Metadata
- Authors
- McAlpine, J., Leon‐Castillo, A., & Bosse, T.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2018-02-28
- Volume
- 244
- Issue
- 5
- Pages
- 538-549
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2793962581
- Cited by
- 254
- References
- 84
- FWCI
- 21.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.